Reviva Pharmaceuticals Warrants
RVPHW
RVPHW was delisted on the 12th of December, 2025.
5 hedge funds and large institutions have $113K invested in Reviva Pharmaceuticals Warrants in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
67% more funds holding
Funds holding: 3 → 5 (+2)
0.06% more ownership
Funds ownership: 0.64% → 0.7% (+0.06%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
45% less capital invested
Capital invested by funds: $203K → $113K (-$90.6K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
+$10.2K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$2.19K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AI
1
Arena Investors
Purchase,
New York
| $56.4K | – | – | – |
|
2
Walleye Capital
New York
| $21.3K | – | – | – |
|
|
BRWA
3
B. Riley Wealth Advisors
Boca Raton,
Florida
| $17.1K | +$10.2K | +11,101 | New |
|
4
Walleye Trading
New York
| $16.2K | – | – | – |
|
|
5
UBS Group
Zurich,
Switzerland
| $1.5K | +$2.19K | +2,382 | New |
|
RVPHW Hedge Fund Activity: Q1 2024 in Review
5 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Reviva Pharmaceuticals Warrants (RVPHW) for Q1 2024, worth a combined $113K — down 45% from $203K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new RVPHW positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was B. Riley Wealth Advisors, opening a new position worth an estimated $10.2K.
- 5 institutional investors held Reviva Pharmaceuticals Warrants (RVPHW) as of Q1 2024, up from 3 in Q4 2023.
- Funds reported $113K of Reviva Pharmaceuticals Warrants stock for Q1 2024, down 45% quarter-over-quarter.
- 2 funds opened new Reviva Pharmaceuticals Warrants positions in Q1 2024 and 0 closed out, a net change of +2 holders.
- The largest Reviva Pharmaceuticals Warrants buyer in Q1 2024 was B. Riley Wealth Advisors, an estimated $10.2K added.
Based on aggregated 13F filings for Q1 2024.